The Voice of India’s MedTech Industry

The Medical Technology Association of India (MTaI) represents the collective voice of the MedTech industry, dedicated to advancing access to high-quality, innovative, and safe healthcare solutions. As a trusted partner, MTaI works closely with the Government of India, healthcare professionals, and global MedTech leaders to shape a robust, inclusive, and future-ready healthcare ecosystem.

Our Impact

9+
Years of impactful policy shaping advocacy
70+
Leading Medtech companies represented
200+
Engagements with government and policy bodies

Our Members

65+ global MedTech leaders united in advancing equitable, high-quality healthcare for India.

MTaI in News

Discover the latest coverage of MTaI’s work in advancing policy, fostering regulatory improvements, and supporting progress across India’s MedTech sector

West Asia-linked helium shortage threatens MRI services in India

West Asia-linked helium shortage threatens MRI services in India

20 Mar 2026 | Industry story

Helium shortage hits MRI supply chains in India, raising scan costs, delay risks, and pushing shift to helium-free tech.

Read More
Helium squeeze disrupts MRI supply chain, pushes up costs for company

Helium squeeze disrupts MRI supply chain, pushes up costs for company

19 Mar 2026 | Industry story

Helium shortage from Qatar disrupts MRI supply chains, raising costs, risks of delays, and pushing shift to helium-free tech.

Read More
India’s MedTech Export Moment

India’s MedTech Export Moment

24 Feb 2026 | Industry story

India’s MedTech exports hinge on regulatory credibility, global integration, and distribution—not just manufacturing scale.

Read More
The Galgotias Episode Sparks a Wider Debate on MedTech

The Galgotias Episode Sparks a Wider Debate on MedTech

20 Feb 2026 | Industry story

Galgotias row sparks debate on tech transparency, pseudo-manufacturing, and need for balanced regulation in India.

Read More
Why India is set a slugfest between global and domestic manufacture

Why India is set a slugfest between global and domestic manufacture

16 Feb 2026 | Industry story

India debates refurbished medical devices: safety, policy gaps, and affordability vs domestic industry concerns.

Read More
US-Bangladesh pact unlikely to impact India's pharma, medtech exports

US-Bangladesh pact unlikely to impact India's pharma, medtech exports

11 Feb 2026 | Industry story

US–Bangladesh trade pact deepens ties, but minimal impact on India’s pharma and medtech exports, experts say.

Read More